InsidersTradesSigma
Follow the LIDDS AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. The latest transaction was filed on 5 March 2021 (Purchase). Among the most active insiders: Daniel Lifveredson. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
LIDDS AB is a Swedish biopharmaceutical company focused on developing treatments for cancer. It is listed on the XSTO market.